Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-039404
Filing Date
2023-06-23
Accepted
2023-06-23 16:29:48
Documents
2
Period of Report
2023-06-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4067
2 POA DOCUMENT poa.txt EX-24 3151
  Complete submission text file 0001209191-23-039404.txt   8625
Mailing Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-443-7400
Harpoon Therapeutics, Inc. (Issuer) CIK: 0001708493 (see all company filings)

EIN.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 20 BERKELEY SQUARE, MAYFAIR LONDON X0 W1J 6EQ
Business Address
Chin Mark (Reporting) CIK: 0001734389 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38800 | Film No.: 231038110